We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Baseline characteristics of the diabetic participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
- Authors
Barzilay, Joshua I.; Jones, Cheryl L.; Davis, Barry R.; Basile, Jan N.; Goff Jr., David C.; Ciocon, Jerry O.; Sweeney, Mary Ellen; Randall, Otelio S.; Barzilay, J I; Jones, C L; Davis, B R; Basile, J N; Goff, D C Jr; Ciocon, J O; Sweeney, M E; Randall, O S; Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Collaborative Research Group
- Abstract
<bold>Objective: </bold>Hypertension (HTN) is a major risk factor for cardiovascular disease (CVD) in the setting of diabetes. There is no consensus on how best to treat hypertension among those with diabetes. Here we describe the characteristics of a cohort of hypertensive adults with diabetes who are part of a large prospective blood pressure study. This study will help clarify the treatment of HTN in the setting of diabetes.<bold>Research Design and Methods: </bold>The Antihypertensive and Lipid-Lowering high-risk hypertensive participants, ages > or = 55 years, designed to determine whether the incidence of fatal and nonfatal coronary heart disease (CHD) and combined cardiovascular events (fatal and nonfatal CHD, revascularization surgery, angina pectoris, congestive heart failure, and stroke) differs between diuretic (chlorthalidone) treatment and three alternative antihypertensive therapies: a calcium channel blocker (amlodipine), an ACE inhibitor (lisinopril), and an alpha-adrenergic blocker (doxazosin). The planned follow-up is an average of 6 years, to be completed March 2002.<bold>Results: </bold>There are 15,297 diabetic individuals in the ALLHAT study (36.0% of the entire cohort). Of these individuals, 50.2% are male, 39.4% are African-American, and 17.7% are Hispanic. Demographic and laboratory characteristics of the cohort are similar to those of other studies of the U.S. elderly population with HTN. The sample size has 42 and 93% confidence, treatments for the two study outcomes.<bold>Conclusions: </bold>The diabetic cohort in ALLHAT wil be able to provide valuable information about the treatment of hypertension in older diabetic patients at risk for incident CVD.
- Subjects
HYPERTENSION; THERAPEUTICS; PEOPLE with diabetes; DIABETES complications; DISEASES
- Publication
Diabetes Care, 2001, Vol 24, Issue 4, p654
- ISSN
0149-5992
- Publication type
journal article
- DOI
10.2337/diacare.24.4.654